ICU Stock Based Compensation from 2010 to 2024

ICUI Stock

USD 160.96 3.00 1.83%

ICU Medical's Stock Based Compensation is increasing with slightly volatile movements from year to year. Stock Based Compensation is estimated to finish at about 42.6 M this year. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2006-03-31

Previous Quarter

11 M

Current Value

11.8 M

Quarterly Volatility

3.4 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check ICU Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ICU Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 240.2 M, Interest Expense of 107.9 M or Total Revenue of 2.4 B, as well as many indicators such as Price To Sales Ratio of 1.01, Dividend Yield of 0.0 or PTB Ratio of 1.08. ICU financial statements analysis is a perfect complement when working with ICU Medical Valuation or Volatility modules.

Check out the analysis of ICU Medical Correlation against competitors.

For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.

Latest ICU Medical's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of ICU Medical over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. ICU Medical's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ICU Medical's overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

ICU Stock Based Compensation Regression Statistics

	Arithmetic Mean	19,263,943
	Geometric Mean	12,505,936
	Coefficient Of Variation	69.65
	Mean Deviation	10,916,480
	Median	19,352,000
	Standard Deviation	13,416,596
	Sample Variance	180T
	Range	42.3M
	R-Value	0.98
	Mean Square Error	6.6T
	R-Squared	0.97
	Slope	2,948,304
	Total Sum of Squares	2520.1T

ICU Stock Based Compensation History

	2024	42.6 M
	2023	40.6 M
	2022	36 M
	2021	27.3 M
	2020	24 M
	2019	21.9 M
	2018	24.2 M

Other Fundumenentals of ICU Medical

Stock Based Compensation To Revenue

ICU Medical Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Short Term Investments	Common Stock	Treasury Stock	Property Plant Equipment	Net Tangible Assets	Current Deferred Revenue	Good Will	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Net Invested Capital	Net Working Capital	Short Term Debt	Capital Stock	Short Long Term Debt
Total Assets		0.94	0.87	0.78	0.92	0.77	0.97	0.9	0.98	-0.36	0.73	0.34	0.96	-0.48	0.96	0.93	0.84	0.03	-0.52	0.89	0.7	0.9	0.96	0.71
Total Stockholder Equity	0.94		0.67	0.93	0.92	0.85	0.83	0.99	0.87	-0.36	0.86	0.44	0.98	-0.17	0.84	0.77	0.96	-0.21	-0.51	0.76	0.74	0.74	0.82	0.59
Net Debt	0.87	0.67		0.4	0.72	0.48	0.97	0.58	0.94	-0.32	0.37	0.1	0.75	-0.83	0.94	0.98	0.51	0.4	-0.44	0.89	0.48	0.96	0.96	0.76
Retained Earnings	0.78	0.93	0.4		0.79	0.76	0.61	0.95	0.67	-0.23	0.9	0.45	0.85	0.11	0.65	0.54	0.89	-0.41	-0.32	0.57	0.73	0.5	0.62	0.39
Accounts Payable	0.92	0.92	0.72	0.79		0.9	0.85	0.91	0.88	-0.41	0.81	0.36	0.93	-0.26	0.81	0.78	0.89	-0.05	-0.65	0.79	0.56	0.69	0.8	0.47
Net Receivables	0.77	0.85	0.48	0.76	0.9		0.64	0.87	0.68	-0.39	0.83	0.37	0.85	-0.02	0.58	0.55	0.89	-0.26	-0.48	0.55	0.37	0.49	0.57	0.35
Total Liab	0.97	0.83	0.97	0.61	0.85	0.64		0.76	0.99	-0.32	0.57	0.24	0.87	-0.69	0.98	0.99	0.68	0.21	-0.49	0.92	0.6	0.96	0.99	0.74
Total Current Assets	0.9	0.99	0.58	0.95	0.91	0.87	0.76		0.81	-0.3	0.9	0.48	0.95	-0.08	0.77	0.7	0.95	-0.33	-0.45	0.69	0.7	0.66	0.75	0.53
Intangible Assets	0.98	0.87	0.94	0.67	0.88	0.68	0.99	0.81		-0.35	0.63	0.27	0.9	-0.62	0.98	0.98	0.74	0.17	-0.52	0.92	0.64	0.94	0.99	0.71
Short Term Investments	-0.36	-0.36	-0.32	-0.23	-0.41	-0.39	-0.32	-0.3	-0.35		-0.28	-0.01	-0.44	0.06	-0.32	-0.28	-0.43	-0.17	0.38	-0.3	-0.32	-0.27	-0.32	-0.22
Common Stock	0.73	0.86	0.37	0.9	0.81	0.83	0.57	0.9	0.63	-0.28		0.37	0.79	0.09	0.57	0.49	0.84	-0.29	-0.31	0.65	0.52	0.42	0.55	0.33
Treasury Stock	0.34	0.44	0.1	0.45	0.36	0.37	0.24	0.48	0.27	-0.01	0.37		0.37	0.15	0.24	0.21	0.46	-0.7	-0.3	0.22	0.26	0.19	0.23	0.15
Property Plant Equipment	0.96	0.98	0.75	0.85	0.93	0.85	0.87	0.95	0.9	-0.44	0.79	0.37		-0.27	0.87	0.82	0.95	-0.09	-0.58	0.78	0.71	0.8	0.86	0.67
Net Tangible Assets	-0.48	-0.17	-0.83	0.11	-0.26	-0.02	-0.69	-0.08	-0.62	0.06	0.09	0.15	-0.27		-0.64	-0.75	0.04	-0.61	0.11	-0.63	-0.07	-0.76	-0.67	-0.6
Current Deferred Revenue	0.96	0.84	0.94	0.65	0.81	0.58	0.98	0.77	0.98	-0.32	0.57	0.24	0.87	-0.64		0.98	0.69	0.2	-0.5	0.91	0.71	0.96	1.0	0.76
Good Will	0.93	0.77	0.98	0.54	0.78	0.55	0.99	0.7	0.98	-0.28	0.49	0.21	0.82	-0.75	0.98		0.61	0.26	-0.45	0.91	0.58	0.98	0.99	0.78
Capital Surpluse	0.84	0.96	0.51	0.89	0.89	0.89	0.68	0.95	0.74	-0.43	0.84	0.46	0.95	0.04	0.69	0.61		-0.31	-0.59	0.6	0.69	0.58	0.67	0.5
Deferred Long Term Liab	0.03	-0.21	0.4	-0.41	-0.05	-0.26	0.21	-0.33	0.17	-0.17	-0.29	-0.7	-0.09	-0.61	0.2	0.26	-0.31		-0.07	0.3	-0.08	0.24	0.23	0.15
Long Term Investments	-0.52	-0.51	-0.44	-0.32	-0.65	-0.48	-0.49	-0.45	-0.52	0.38	-0.31	-0.3	-0.58	0.11	-0.5	-0.45	-0.59	-0.07		-0.46	-0.39	-0.41	-0.48	-0.34
Net Invested Capital	0.89	0.76	0.89	0.57	0.79	0.55	0.92	0.69	0.92	-0.3	0.65	0.22	0.78	-0.63	0.91	0.91	0.6	0.3	-0.46		0.56	0.85	0.93	0.66
Net Working Capital	0.7	0.74	0.48	0.73	0.56	0.37	0.6	0.7	0.64	-0.32	0.52	0.26	0.71	-0.07	0.71	0.58	0.69	-0.08	-0.39	0.56		0.58	0.68	0.46
Short Term Debt	0.9	0.74	0.96	0.5	0.69	0.49	0.96	0.66	0.94	-0.27	0.42	0.19	0.8	-0.76	0.96	0.98	0.58	0.24	-0.41	0.85	0.58		0.97	0.88
Capital Stock	0.96	0.82	0.96	0.62	0.8	0.57	0.99	0.75	0.99	-0.32	0.55	0.23	0.86	-0.67	1.0	0.99	0.67	0.23	-0.48	0.93	0.68	0.97		0.77
Short Long Term Debt	0.71	0.59	0.76	0.39	0.47	0.35	0.74	0.53	0.71	-0.22	0.33	0.15	0.67	-0.6	0.76	0.78	0.5	0.15	-0.34	0.66	0.46	0.88	0.77

Click cells to compare fundamentals

About ICU Medical Financial Statements

Investors use fundamental indicators, such as ICU Medical's Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although ICU Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.

	Last Reported	Projected for Next Year
Stock Based Compensation	40.6 M	42.6 M
Stock Based Compensation To Revenue	0.02	0.01

Currently Active Assets on Macroaxis

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft
HBI	Hanesbrands
STLD	Steel Dynamics

When determining whether ICU Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ICU Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Icu Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Icu Medical Stock:

How To Invest In ICU

Details

Is ICU Stock a good investment?

Details

What is ICU Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of ICU Medical Correlation against competitors.

For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.

You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICU Medical. If investors know ICU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICU Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.24)

Earnings Share

(4.56)

Revenue Per Share

96.302

Quarterly Revenue Growth

0.065

Return On Assets

0.0066

The market value of ICU Medical is measured differently than its book value, which is the value of ICU that is recorded on the company's balance sheet. Investors also form their own opinion of ICU Medical's value that differs from its market value or its book value, called intrinsic value, which is ICU Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICU Medical's market value can be influenced by many factors that don't directly affect ICU Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ICU Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICU Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICU Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

ICU Stock Based Compensation from 2010 to 2024

Latest ICU Medical's Stock Based Compensation Growth Pattern

ICU Stock Based Compensation Regression Statistics

ICU Stock Based Compensation History

Other Fundumenentals of ICU Medical

ICU Medical Stock Based Compensation component correlations

About ICU Medical Financial Statements

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY